Literature DB >> 18949570

Effects of Nandrolone and TGF-beta1 in growing rabbits with osteopenia induced by over-supplementation of calcium and vitamin D3.

H P Aithal1, P Kinjavdekar, A M Pawde, G R Singh, A K Pattanaik, V P Varshney, T K Goswami, H C Setia.   

Abstract

The study was undertaken to find out the effects of over supplementation of dietary calcium and vitamin D3 on the mineralization of growing skeleton, taking rabbit as an animal model; further to study the effects of Nandrolone deconoate and TGF-beta1 on the mineralization of osteopenic bones. Twenty four New Zealand White rabbits of either sex, 60 day old, were randomly divided in 4 equal groups, A, B, C and D. The animals of groups B, C and D were administered with oral supplementation of calcium (2000 mg/kg of standard rabbit feed) and vit-D3 (1000 IU/kg of standard feed) for 60 days. The animals of group A were given standard ration without any supplementation. After 60 days, the Ca-vit.D3 supplementation was discontinued; and the animals of group C were administered with TGF-beta1 (10 ng, i.m.) once in every three days and animals of group D were given Nandrolone deconoate (10 mg, i.m.) once every week for 30 days, whereas in animals of group B, no treatment was given. All the animals were evaluated based on different observations like body weight, radiographic observations, circulating biochemical and hormone profile (plasma Ca, IP, AP, OC and iPTH) every 15 days up to 60 days after initiation of treatment. The results indicated that the body weight of rabbits in different groups increased gradually and steadily at different intervals till the end of observation period, however, the increase was non-significantly more in group D. The CI in group A increased gradually at different intervals; whereas in groups B, C and D, there was no appreciable increase in the CI during the period of Ca-vit.D3 supplementation, suggesting development of osteopenia. Treatment with TGF-beta1 did not increase the CI significantly, whereas Nandrolone treatment resulted in significant increase in the CI on days 45 and 60. The plasma Ca levels showed slight but gradual increase from day 0 to 60 in almost all groups. Subsequently also, there was no marked change at different intervals in groups A and B; however, significant reduction in plasma Ca was noticed in group C on 15(th) day and in group D on 60(th) day after initiation of treatment. Plasma IP levels in groups B and C showed a decreasing trend up to day 60. After discontinuation of Ca-vit.D3 supplementation, in group B, it further decreased to remain significantly lower on 15(th) day, and in groups C and D, it increased significantly on 60(th) post-treatment day. There was no significant change in the AP activity during the entire period of study in group A; whereas significant reduction in AP activity was measured on 30(th) and 60(th) days of treatment in groups B and C, and on 15(th) day of treatment in group D. Plasma iPTH values did not show any significant change at any interval during the first 60 days in all groups. On 30(th) and 60(th) days of treatment, the mean iPTH level remained significantly lesser in group B. In all groups treated with over supplementation of Ca and vit.D3, there was a non-significant increase in the plasma OC levels up to day 60; however, there was no significant difference between the groups. It can be concluded that additional supplementation of Ca and vit.D3 results in osteopenia in growing rabbits. Administration of Nandrolone helps to increase the mineral density in osteopenic bones, whereas TGF-beta1 does not seem to have positive effect on the skeletal mineralization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18949570     DOI: 10.1007/s11259-008-9181-4

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  23 in total

1.  Effects of diets with different calcium and phosphorus contents on the skeletal development and blood chemistry of growing great danes.

Authors:  I Schoenmakers; H A Hazewinkel; G Voorhout; C S Carlson; D Richardson
Journal:  Vet Rec       Date:  2000-12-02       Impact factor: 2.695

2.  Pregnancy and lactational osteoporosis. Animal model: porcine lactational osteoporosis.

Authors:  G R Spencer
Journal:  Am J Pathol       Date:  1979-04       Impact factor: 4.307

3.  Origins of serum alkaline phosphatase.

Authors:  J M Yong
Journal:  J Clin Pathol       Date:  1967-07       Impact factor: 3.411

Review 4.  Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

Authors:  A B Roberts; M B Sporn
Journal:  Growth Factors       Date:  1993       Impact factor: 2.511

5.  The effects of nandrolone decanoate on bone mass and metabolism in ovariectomized rats with osteopenia.

Authors:  X Li; M Takahashi; K Kushida; S Shimizu; H Hoshino; M Suzuki; T Inoue
Journal:  J Bone Miner Metab       Date:  2000       Impact factor: 2.626

6.  Effects of transforming growth factor beta on cells derived from bone and callus of patients with osteogenesis imperfecta.

Authors:  M Mörike; E Windsheimer; R Brenner; A Nerlich; G Bushart; W Teller; U Vetter
Journal:  J Orthop Res       Date:  1993-07       Impact factor: 3.494

7.  The action of anabolic steroids on bone in experimental animals.

Authors:  L P Schot; A H Schuurs; H J Kloosterboer
Journal:  Wien Med Wochenschr       Date:  1993

Review 8.  Relationship between nutrition and bone growth in large and giant dogs.

Authors:  K Dämmrich
Journal:  J Nutr       Date:  1991-11       Impact factor: 4.798

9.  Diet and exercise as potential risk factors for osteochondritis dissecans in dogs.

Authors:  M R Slater; J M Scarlett; S Donoghue; R E Kaderly; B N Bonnett; J Cockshutt; H N Erb
Journal:  Am J Vet Res       Date:  1992-11       Impact factor: 1.156

10.  Matrix vesicles and calcification of rachitic rat osteoid.

Authors:  T F Johnson; D C Morris; H C Anderson
Journal:  J Exp Pathol       Date:  1989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.